Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study-Reference-Cited by-同舟云学术

Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study

Published:2016-12 Issue:12 Volume:27 Page:2242-2250
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kanda S.,Goto K.,Shiraishi H.,Kubo E.,Tanaka A.,Utsumi H.,Sunami K.,Kitazono S.,Mizugaki H.,Horinouchi H.,Fujiwara Y.,Nokihara H.,Yamamoto N.,Hozumi H.,Tamura T.

Funder

Ono Pharmaceuticals

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/12/2242/8623022/mdw416.pdf

Reference19 articles.

1. Paclitaxel–carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006

2. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer;Scagliotti;J Clin Oncol,2008

3. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy;Shepherd;J Clin Oncol,2000